Notably, CD19‐CAR‐DNTs elicited remarkable cytotoxicity against B‐NHL cell lines (Raji and JeKo‐1), B‐cell acute lymphoblastic leukaemia (B‐ALL) cell lines (NALM‐6 and SUP‐B15), and primary B‐ALL blasts (Figure 6a, b). The gene discussed is CD19; the disease is non-Hodgkin lymphoma.